Pricing Transparency: Expect clear, detailed pricing information, including payment options and insurance coverage details
For this drug, the ongoing SOUL trial has shown promising preliminary results, indicating a 14% reduction in the risk of MACE (84)
Liver disease, including cirrhosis, hepatitis, and fatty liver, prohibits Glutathione IV administration
This weight reduction is often sustained during ongoing treatment, although discontinuing the medication may lead to weight regain
You have a history of diabetic retinopathy
Astragalus polysaccharides (APS) protected ARPE-19 cells, a spontaneously arising retinal pigment epithelium (RPE) cell line, and rat primary RPE cells under high glucose conditions through miR-182/Bcl-2 and miR-204/SIRT1 signaling pathways, restraining mitochondrial damage, endoplasmic reticulum (ER) stress and cell apoptosis [41, 42], ultimately improving diabetic retinopathy (DR) RPE cell function